Bookmark and Share

2013 Divisional Bibliography

Peer Reviewed

  1. Agarwal R, Weir MR. Treated hypertension and the white coat phenomenon: office readings are inadequate measures of efficacy. J Am Soc Hypertens. 2013 May-June;7(3):236-43.
  2. Agarwal R, Weir MR. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis. J Hypertens. 2013 Aug;31(8):1692-701.
  3. Babich V, Vadnagara K, Di Sole F. The biophysical and molecular basis of intracellular pH sensing by Na+/H+ exchanger-3. FASEB J. 2013 Nov;27(11):4646-58.
  4. Cai J, Han Y, Ren H, Chen C, He D, Zhou L, Eisner GM, Asico LD, Jose PA, Zeng C. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol. 2013 Aug;5(4):227-38.
  5. Chen Y, Asico LD, Zheng S, Villar VA, He D, Zhou L, Zeng C, Jose PA. Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension. 2013 Nov;62(5):927-33.
  6. Costa NA, Kshirsagar AV, Wang L, Detwiler RK, Brookhart MA. Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality. Transplantation. 2013 Nov 15;96(9):807-13.
  7. Cuevas S, Villar VA, Jose PA, Armando I. Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci. 2013 Aug 27;14(9):17553-72.
  8. Davey A, Elias MF, Robbins MA, Seliger SL, Dore GA. “Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory”. Nephrol Dial Transpl 2013; 28(7): 1810-9.
  9. Diamantidis CJ, Zuckerman M, Fink W, Agarwal S, Prakash D, Fink JC. Usability testing and acceptance of a multi-platform IT Medication Inquiry System (MIS) in chronic kidney disease (CKD). Am J Kidney Dis 61(4):644-6, 2013.
  10. Diamantidis CJ, Fink W, Yang S, Zuckerman MA, Ginsberg J, Hu P, Xiao Y, Fink JC. Directed use of the Internet for health information by patients with chronic kidney disease: results from Safe Kidney Care. J Med Internet Res 15:251-257, 2013.
  11. Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens. 2013 Jan;22(1):65-76.
  12. Fried LF, Emmanuale N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O’Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P. “Combined Angiotensin Inhibition for Treatment of Diabetic Nephropathy” N Engl J Med, N Engl J Med. 2013 Nov 14;369(20):1892-903.
  13. Gildea JJ, Lahiff DT, Van Sciver RE, Weiss RS, Shah N, McGrath HE, Schoeffel CD, Jose PA, Carey RM, Felder RA. A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt-sensitivity of blood pressure in exfoliated human renal proximal tubule cells: The virtual renal biopsy. Clin Chim Acta. 2013 Jun 5;421:236-42.
  14. Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD. Red blod cell transfusion use in patients with chronic kidney disease. Neph Dial Transplant 28:1504-15, 2013.
  15. Glick D, deFilippi CR, Christenson R, Gottdiener JS, Seliger SL. “Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community dwelling older adults at low baseline risk” J Am Coll Cardiology HF. 2013; 353-360.
  16. Gordon EJ, Fink JC, Fischer MJ Telenephrology: a novel approach to improve coordinated and collaborative care for chronic kidney disease. Neph Dial Transplant 28:972-81, 2013.
  17. Hartley IR, Ginsberg JS, Diamantidis CJ, Zhan M, Walker L, Rattinger RB, Fink JC. Consideration of ICD-9 code-derived disease-specific safety indicators in CKD. Clin J Am Soc Nephrol 8:2123-31 2013.
  18. Jiang X, Wang W, Ning B, Liu X, Gong J, Gan F, Gao X, Zhang L, Jose PA, Qin C, Yang Z. Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults. Clin Exp Hypertens. 2013;35(1):74-8.
  19. Kasiske BL, Anderson-Haag T, Ibrahim HN, Pesavento TE, Weir MR, Nogueira JM, Cosio FG, Kraus ES, Rabb HH, Kalil RS, Posselt AA, Kimmel PL, Steffes MW. A Prospective Controlled Study of Kidney Donors: Baseline and 6-Month Follow-up. Am J Kidney Dis. 2013 Sept;62(3):577-86.
  20. Konkalmatt PR, Beyers RJ, O'Connor DM, Xu Y, Seaman ME, French BA. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling. Circ Cardiovasc Imaging. 2013 May 1;6(3):478-86.
  21. Konkalmatt PR, Deng D, Thomas S, Wu MT, Logsdon CD, French BA, Kelly KA. Plectin-1 targeted AAV vector for the molecular imaging of pancreatic cancer. Front Oncol. 2013 Apr 18;3:84.
  22. Köttgen A, Albrecht E, Teumer A, Parsa A. et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013 Feb;45(2):145-54.
  23. Kuppachi S, Thomas B, Kokko KE. BK virus in the kidney transplant patient. Am J Med Sci 2013 Jun;345(6):482-488.
  24. Lewis JP, Ryan K, O'Connell JR, Horenstein RB, Damcott CM, Gibson Q, Pollin TI, Mitchell BD, Beitelshees AL, Pakzy R, Tanner K, Parsa A, Tantry US, Bliden KP, Post WS, Faraday N, Herzog W, Gong Y, Pepine CJ, Johnson JA, Gurbel PA, Shuldiner AR. Genetic Variation in PEAR1 is Associated with Platelet Aggregation and Cardiovascular Outcomes. Circ Cardiovasc Genet. 2013 Apr;6(2):184-92.
  25. Liu T, Jose PA. Gastrin Induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C-dependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human. Endocrinology. 2013 Feb;154(2):865-75.
  26. Longstreth WT Jr, Kronmal RA, Thompson JL, Christenson RH, Levine SR, Gross R, Brey RL, Buchsbaum R, Elkind MS, Tirschwell DL, Seliger SL, Mohr JP, deFilippi CR. “Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.” Stroke. 2013 Mar;44(3):714-9.
  27. Lu, Q., Yang, Y., Villar, V.A., Asico, L., Jones, J.E., Yu, P., Li, H., Weinman, E.J., Eisner, G.M., and Jose, P.A.: D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res 36:684-690, 2013.
  28. McGillicuddy JW, Gregowski MJ, Weiland AK, Rock PA, Brunner-Jackson BM, Patel SK, Thomas BS, Taber DJ, Chavin KD, Baliga PK, Treiber FA. Mobile Health Medication. Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof of Concept Randomized Controlled Trial. JMIR Research Protocols Sept 4 2013
  29. Mindikoglu AL, Weir MR. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013;38(4):345-54.
  30. Mohanlal, V., Haririan, A., and Weinman, E.J.: Bradycardia without "classical" EKG changes in hyperkalemic hemodialysis patients. Clin. Neph. 80:464-468, 2013.
  31. Mullins CD, Jain R, Weir MR, Franey CS, Shih YC, Pradel FG, Bikov K, Bartlett ST. Benefits improvement and protection act’s impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease. Transplantation. 2013 Feb 15;95(3):463-9.
  32. Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA. “Incidence of stroke before and after dialysis initiation in older patients” J Am Soc Nephrol 2013 24(7): 1166-73.
  33. Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, Nambi V, McGuire DK, Omland T, de Lemos JA. “Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.” J Am Coll Cardiol 2013; 61(2): 187-95.
  34. Nesbitt SD, Shojaee A, Maa JF, Weir MR. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study). J Hum Hypertens. 2013 Jul;27(7):445-52.
  35. Papadimitriou JC, Drachenberg CB, Ramos E, Kukuruga D, Klassen DK, Ugarte R, Nogueira J, Cangro C, Weir MR, Haririan A. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and cause for biopsies. Transplantation. 2013 Jan 15;95(1):128-36.
  36. Parsa A, Fuchsberger C, Kottgen et al. (over 150 authors). Common Variants in Mendelian Kidney Disease Genes and Their Association with Renal Function and CKD. J Am Soc Nephrol. 2013 Dec;24(12):2105-17.
  37. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; the AASK and CRIC Study Investigators. APOL1Risk Variants, Race and progression of Chronic Kidney Disease Progression. N Engl J Med. 2013. Dec 5. Dec 5;369(23):2183-96.
  38. Posadas A, Derrick M, Thomas B, Twombley K. Recent Advances in the Diagnosis and Treatment of Antibody Mediated Injury in Pediatric Kidney Transplants. Journal of Clinical Pediatric Nephrology Vol. 2/July – December 2013
  39. Roshanravan B, Robinson-Cohen C, Patel KV, Ayers E, Littman AJ, de Boer IH, Ikizler TA, Himmelfarb J, Katzel LI, Kestenbaum B, Seliger S. “Association between physical performance and all-cause mortality in CKD.” J Am Soc Nephrol 2013; 24(5): 822-30.
  40. Salzberg DJ, Karadsheh FF, Haririan A, Reddivari V, Weir MR. Specific Management of Anemia and Hypertension in Renal Transplant Recipients: Influence of Renin-Angiotensin System Blockade. Am J Nephrol. 2013 Dec 19;39(1):1-7.
  41. Salazar MN, Wray D, Denlinger C, Srinivas T, Thomas B, Posadas A. Mediastinal mass and pericardial tamponade in a renal transplant recipient: A Rare Case of Nocardia Infection. Am J Case Rep 2013 Aug 5;14:295-299.
  42. Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J. “Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD”. Am J Kidney Dis. 2013 Jan;61(1):67-73.
  43. Spencer RJ, Wendell CR, Giggey PP, Seliger SL, Katzel LI, Waldstein SR “Judgment of Line Orientation: an examination of eight short forms.” J Clin Exp Neuropsychol 2013; 35(2):160-6.
  44. Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are Thiazide Diuretics Safe and Effective Anti-hypertensive Therapy in Kidney Transplant Recipients? Am J Nephrol 2013;38:420–429.
  45. Taler SJ, Agarwal R, Bakris GL, Flynn JT, Nilsson PM, Rahman M, Sanders PW, Textor SC, Weir MR, Townsend RR. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD. Am J Kidney Dis. 2013 Aug;62(2):201-13.
  46. Tlaxca JL, Rychak JJ, Ernst PB, Konkalmatt PR, Shevchenko TI, Pizzaro TT, Rivera-Nieves J, Klibanov AL, Lawrence MB. Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease. J Control Release. 2013 Feb 10;165(3):216-25.
  47. Thomas B, Taber DJ, Srinivas TR. Hypertension after Kidney Transplantation: A Pathophysiologic Approach. Curr Hypertens Rep Aug 11 2013.
  48. Townsend RR, Weir MR. Angiotensin II blockade after kidney transplantation. J Am Soc Nephrol. 2013 Feb;24(2):167-8.
  49. Villar VA, Jones JE, Armando I, Asico LD, Escano CS Jr, Lee H, Wang X, Yang Y, Pascua-Crusan AM, Palmes-Saloma CP, Felder RA, Jose PA. Sorting nexin 1 loss results in D5 dopamine receptor dysfunction in human renal proximal tubule cells and hypertension in mice. J Biol Chem. 2013 Jan 4;288(1):152-63.
  50. Villar VA, Armando I, Sanada H, Frazer LC, Russo CM, Notario PM, Lee H, Comisky L, Russell HA, Yang Y, Jurgens JA, Jose PA, Jones JE. Novel role of sorting nexin 5 in renal D1 dopamine receptor trafficking and function: implications for hypertension. FASEB J. 2013 May;27(5):1808-19.
  51. Wang X, Escano CS, Asico L, Jones JE, Barte A, Lau Y-S, Jose PA, Armando I. Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor deficient mice. Hypertension. 2013 Aug;62(2):295-301.
  52. Wang Y, Han Y, Yang J, Wang Z, Liu L, Wang W, Zhou L, Wang D, Tan X, Fu C, Jose PA, Zeng C. Relaxant effect of all-trans retinoic acid via NO-sGC-cGMP pathway and calcium-activated potassium channels in rat mesenteric artery. Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H51-7.
  53. Watnick TJ, Germino GG. Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated. Nat Rev Nephrol. 2013 May;9(5):249-50.
  54. Weber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velazquez EJ, Pitt B. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet. 2013 Feb 16; 381(9866):537-45.
  55. Weber MA, Bakris GL, Hester A, Weir MR, Hua TA, Zappe D, Dahlof B, Velazquez EJ, Pitt B, Jamerson K. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med. 2013 June;126(6):501-8.
  56. Weber MA, Bakris GL, Weir MR, Jamerson K. Obesity, blood pressure, and cardiovascular outcomes – Author’s reply. Lancet. 2013 Jun 8;381(9882):1982-3.
  57. Weir MR, Shojaee, Maa JF. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or & lt; 65 years with uncontrolled hypertension on prior monotherapy. Postgrad Med. 2013 Mar; 125(2): 124-34.
  58. Weinman, E.J., Light, P.D., and Suki, W.N.: Phosphate absorption from the gastrointestinal tract in patients with renal insufficiency and the development of cardiovascular disease. Amer J Kidney Dis 62:1006-1011, 2013.
  59. Xie WB, Shi N, Guo X, Tang J, Ju W, Han J, Liu T, Bottinger EP, Chai Y, Jose PA, Chen SY. Smad2 and MRTFB cooperatively regulate vascular smooth muscle differentiation from neural crest cells. Circ Res. 2013 Sep 27;113(8):e76-86.
  60. Yaffe K, Ackerson L, Hoang TD, Go AS, Maguire MG, Ying GS, Daniel E, Bazzano LA, Coleman M, Cohen DL, Kusek JW, Ojo A, Seliger S, Xie D, Grunwald JE. “Retinopathy and cognitive impairment in adults with CKD.” Am J Kidney Dis, 2013;61(2):219-27.
  61. Yu P, Villar VA, Jose PA. Methods for the study of dopamine receptors within lipid rafts of kidney cells. Methods Mol Biol. 2013;964:15-24.
  62. Zhang Z, Payne K, Cao C, Pallone TL. Mural propagation of descending vasa recta responses to mechanical stimulation. Am J Physiol Renal Physiol. 2013 305(3):F286-94.

Non Peer Reviewed

  1. Seliger SL, Weiner DE. “Cognitive impairment in dialysis patients: focus on the blood vessels? [Invited Editorial]” Am J Kidney Dis, 2013;61(2):187-90
  2. Seliger SL, deFilippi CR. High-sensitive cardiac troponin assays: more information, more challenges. Coron Artery Dis 2013; 24(8): 625-7 [Invited Review]

Book Chapters

  1. Becker S, Kribben A, Meister S, Königsmann T, Diamantidis CJ, Mertens A, Schiffel A, Mitchell A. (2013). “Nutzerprofile einer Smartphoneapplikation zur Unterstützung der Therapieadhärenz - Erfahrungen aus dem iNephro Projekt” in P . Haas, S.C. Semler, S.H. Schug und J. Schenkel: Nutzung, Nutzer, Nutzen von Telematik in der Gesundheitsversorgung – eine Standortbestimmung. 18. Nationales Forum für Gesundheitstelematik und Telemedizin.
  2. Jose PA, Felder RA, Eisner GM. Paracrine regulation of renal function by dopamine. Seldin and Giebisch's The Kidney: Physiology and Pathophysiology (5th edition). Alpern RJ, Moe OW, Caplan M (eds). Academic Press, 2013, pp. 539-91.
  3. Pallone TL, Cao C. Renal Cortical and Medullary Microcirculations: Structure and Function. In: The Kidney: Physiology and Pathophysiology. 5th edition. pp 803-857. Eds. Alpern C., Caplan M.J., and Moe, O.W. and Hebert S. Elsevier Press, San Diego, CA, 2013.